Spire Health is a global leader in delivering continuous health-sensing solutions with a focus on continuous respiration sensing and high-adherence, patient-friendly ambulatory monitoring. The company's mission is to utilize the power of algorithms and sensors to improve health outcomes by providing patients and physicians with actionable data. Spire Health collaborates with partners across a range of health conditions, including chronic obstructive pulmonary disease (COPD), congestive heart failure, asthma, sleep disorders, and anxiety. Founded in 2013, Spire Health operates within the Biotechnology, Hardware, Health Care, and Health and Wellness industries. The latest investment in Spire Health was a Venture - Series Unknown round on 15 July 2021. The specific investors involved in this round are not disclosed.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture - Series Unknown | Unknown | - | 15 Jul 2021 | |
Venture - Series Unknown | Unknown | - | 29 Apr 2020 | |
Seed | Unknown | - | 19 Aug 2019 | |
Seed | Unknown | - | 12 Jun 2018 | |
Funding Round | Unknown | - | 10 Feb 2016 |
No recent news or press coverage available for Spire Health.